Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / EvolveImmune Therapeutics Holding Company, LLC

EvolveImmune Therapeutics Holding Company, LLC

Stage unknownBranford, CTBiotechnology
Facts
Year of incorporation
2019sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Oct 22, 2024
    Form D equity offering · $20.0M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “EvolveImmune Therapeutics Holding Company, LLC filed Form D: $20,000,003 sold of $20,000,003, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
1 officers, 5 directors
Timeline
1
  1. Nov 1, 2024
    EvolveImmune Therapeutics Holding Company, LLC filed Form D: $20,000,003 sold of $20,000,003, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company